Overview

An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis

Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the long-term safety and efficacy of TS-152 in subjects with Rheumatoid Arthritis who have completed the previous study (TS152-3000-JA study or TS152-3001-JA study).
Phase:
Phase 3
Details
Lead Sponsor:
Taisho Pharmaceutical Co., Ltd.